PRESS-RELEASE ·Filed Oct 22, 2026
Press release · Earnings
Price Chart
Loading chart...
Executive Summary
Kiniksa Pharmaceuticals International, Plc announced it will report its Q3 2026 results on October 27, 2026.
Key Facts
- Kiniksa Pharmaceuticals International, Plc announced it will report its Q3 2026 results on October 27, 2026.
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3386872 |
14 reports for KNSA
60% Hit rate @ T+60 Went positive at some point 5 of 5 best @ T+60▲ +17.08%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 3d ago | 8-K | $80.79 | awaiting T+60 | — | $73.48 (−9.05%) |
Oct 22, 2026 3d ago | Press Release | $80.79 | awaiting T+60 | — | $73.48 (−9.05%) |
Sep 3, 2026 7w ago | 144 | $77.91 | awaiting T+60 | — | $73.48 (−5.69%) |
Jul 28, 2026 12w ago | 8-K | $79.44 $79.70 | ▲ +0.33% | ▼ −4.02% | $73.48 (−7.50%) |
Jul 28, 2026 12w ago | Press Release | $79.44 $79.70 | ▲ +0.33% | ▼ −4.02% | $73.48 (−7.50%) |
May 26, 2026 21w ago | 8-K | $51.84 $78.47 | ▲ +51.37% | ▲ +49.49% | $73.48 (+41.74%) |
May 1, 2026 25w ago | 8-K | $57.62 $80.92 | ▲ +40.44% | ▲ +38.58% | $73.48 (+27.53%) |
Apr 28, 2026 25w ago | 144 | $52.99 $62.84 | ▼ −18.59% | ▼ −14.48% | $73.48 (−38.67%) |
Apr 28, 2026 25w ago | Press Release | $53.85 $63.05 | ▲ +17.08% | ▲ +13.10% | $73.48 (+36.45%) |
Apr 28, 2026 25w ago | Insider Cluster | $53.85 $63.05 | ▲ +17.08% | ▲ +13.10% | $73.48 (+36.45%) |
Showing 10 of 14
US Market Status
Market Open — Closes in 4h 55m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers